Immix Biopharma, Inc. IMMX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.94M-18.9% | -$29.4M-24.8% | -$23.56M-1.9% | -$23.13M-10.6% | -$20.91M+3.6% | ||
| $299.17K+21.7% | $245.75K+14.7% | $214.24K+74.6% | $122.7K+80.2% | $68.08K+107% | ||
| $2.15M-12.0% | $2.44M-5.2% | $2.58M-9.3% | $2.84M-3.6% | $2.95M-2.5% | ||
| -$32.07M-34.0% | -$23.93M-66.4% | -$14.38M-14.9% | -$12.51M-0.4% | -$12.45M+14.7% | ||
| $697.7K-4.8% | $732.93K-31.8% | $1.07M+10.4% | $974.04K+3.2% | $943.48K-19.9% | ||
| -$11.95M-65.6% | -$7.21M-571% | -$1.07M-10.4% | -$974.04K-3.2% | -$943.48K+19.9% | ||
| —— | —— | —— | —— | —— | ||
| $63.33M-16.9% | $76.25M— | —— | —— | —— | ||
| -$32.77M-32.9% | -$24.66M-59.6% | -$15.45M-14.6% | -$13.48M-0.6% | -$13.4M+15.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immix Biopharma, Inc. generate?
- Immix Biopharma, Inc. (IMMX) generated -$32.1M in operating cash flow over the trailing twelve months.
- What is Immix Biopharma, Inc.'s free cash flow?
- After $697.7K of capital expenditures, Immix Biopharma, Inc.'s free cash flow was -$32.8M over the trailing twelve months, down 144.6% year over year.
- Where does Immix Biopharma, Inc.'s cash flow data come from?
- Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.